Clofarabine
In the US, Clofarabine (clofarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Lymphoblastic Leukemia.
US matches:
UK matches:
- CLOFARABINE 1 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (Leaflet)
- CLOFARABINE ACTAVIS 1 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (Leaflet)
- CLOFARABINE CADUCEUS 1 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (Leaflet)
- CLOFARABINE SANDOZ 1 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (Leaflet)
- CLOFARABINE TEVA 1 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION. (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01BB06
CAS registry number (Chemical Abstracts Service)
0123318-82-1
Chemical Formula
C10-H11-Cl-F-N5-O3
Molecular Weight
303
Therapeutic Categories
Immunosuppressant
Antipsoriatic
Cytostatic agent: Antimetabolite
Chemical Names
2-Chlor-9-(2-deoxy-2-fluor-beta-D-arabinofuranosyl)adenin
2-Chlor-9-(2-desoxy-2-fluor-beta-D-arabinofuranosyl)purin-6-amin (IUPAC)
2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine (WHO)
9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- (USAN)
Foreign Names
- Clofarabinum (Latin)
- Clofarabin (German)
- Clofarabine (French)
- Clofarabina (Spanish)
Generic Names
- Clofarabine (OS: USAN, BAN, JAN)
- C1-F-Ara-A (IS)
- CAfdA (IS)
- Clofarex (IS)
- Clolar (IS)
Brand Names
- Clofazic
Raffo, Argentina - Clofazic (Clofarabine and Sodium Chloride)
Tecnofarma, Chile - Clolar
Genzyme, United States; sanofi-aventis, Canada - Evoltra
Genzyme, Belgium; Genzyme, Czech Republic; Genzyme, Germany; Genzyme, Greece; Genzyme, Israel; Genzyme, Italy; Genzyme, Lithuania; Genzyme, Norway; Genzyme, Poland; Genzyme, Romania; Genzyme Europe, Austria; Genzyme Europe, Cyprus; Genzyme Europe, Slovenia; Hospira, Australia; Hospira, New Zealand; Penn Pharmaceutical, Latvia; Sanofi, Germany; Sanofi, United Kingdom; Sanofi, Ireland; Sanofi, Japan; Sanofi, Sweden; Sanofi Aventis, Spain; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand - Folotyn
Mundipharma, Singapore
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
